Chlamydia Testing: Why Regular Screening Matters

Chlamydia is the most commonly reported STD in the United States, and regular testing is the only reliable way to detect it. Up to 75% of infected women and a significant proportion of infected men have no symptoms at all. Without testing, chlamydia can persist undetected for months or years, causing irreversible damage to fertility and increasing susceptibility to HIV.

• Chlamydia is the most reported STD in the US — over 1.6 million cases annually, with the true number significantly higher

• Up to 75% of infections in women produce no symptoms

• Untreated chlamydia is a leading cause of preventable infertility in women

• Annual testing is recommended for all sexually active women under 25

• Chlamydia is fully curable with a single course of antibiotics when caught early

Why Regular Testing Matters More Than Symptom-Watching

The standard advice to “get tested if you have symptoms” fails entirely for chlamydia. The majority of people with chlamydia — particularly women — will never notice any indication that something is wrong. The bacteria infects the cervix and fallopian tubes silently, triggering a low-grade immune response that causes cumulative damage over months without ever producing discharge, pain, or any other obvious sign.

By the time symptoms do appear — pelvic pain, unusual discharge, bleeding between periods — the infection has often already progressed to Pelvic Inflammatory Disease, with fallopian tube inflammation that may have already begun causing scarring. Waiting for symptoms means testing after the damage has started. Regular scheduled testing, by contrast, catches the infection before complications develop.

Who Should Get Tested and How Often

The CDC recommends annual chlamydia testing for all sexually active women under 25, and for older women with new or multiple sexual partners or inconsistent condom use. The recommendation does not require symptoms. Annual testing for MSM (men who have sex with men) is also recommended at all anatomical sites of exposure — urethral, rectal, and pharyngeal. For heterosexual men without specific risk factors, routine chlamydia screening is not universally recommended, though it is advisable for men with multiple partners or inconsistent condom use.

People at higher risk should test more frequently — every 3 to 6 months is appropriate for those with multiple partners, those not using condoms consistently, or anyone whose partner has been diagnosed with chlamydia.

How Chlamydia Is Tested

Chlamydia testing is quick, non-invasive, and highly accurate. The standard test is a Nucleic Acid Amplification Test (NAAT), which detects chlamydia DNA using PCR technology. For most people, this means providing a urine sample — no swab needed. Vaginal swabs (self-collected or clinician-collected) are also used and are slightly more sensitive than urine for women. Rectal and throat swabs are needed to detect chlamydia at those sites if relevant. Home testing kits are widely available and allow testing without a clinic visit, with results available online within a few days.

What Happens If It Goes Untreated

Untreated chlamydia in women can ascend from the cervix to the uterus, fallopian tubes, and ovaries, causing Pelvic Inflammatory Disease. PID causes fallopian tube scarring that blocks or impairs egg transit, leading to tubal factor infertility. It also significantly increases the risk of ectopic pregnancy — a potentially life-threatening condition where a fertilised egg implants in the fallopian tube rather than the uterus. Chronic pelvic pain is another consequence of repeated or untreated PID episodes. In men, untreated chlamydia can cause epididymitis — inflammation of the tube at the back of the testicle — which can affect sperm quality and fertility. Chlamydia also increases HIV susceptibility by causing genital inflammation that disrupts the normal protective barriers.

Treatment

Chlamydia is easily and completely curable. The standard treatment is a 7-day course of doxycycline (100mg twice daily), or a single 1g dose of azithromycin. Doxycycline is currently the preferred option in most guidelines as it has a higher cure rate. All recent sexual partners should be informed and tested or treated. Sexual activity should be avoided for 7 days after completing a single-dose treatment, or until a 7-day course is finished. A test of cure is recommended 3–4 weeks after treatment to confirm clearance.

Tips for Staying on Top of Testing

• Book annual testing as a routine — link it to another annual appointment (GP check-up, contraception review, gynaecology visit) so it does not get forgotten.

• Use home testing kits if clinic attendance is inconvenient — they are accurate, discreet, and require only a urine sample.

• Test after every new sexual partner — do not wait for the annual cycle if you have had unprotected sex with someone new.

• Tell your partner if you test positive — they need to be tested and treated too, or reinfection will occur.

• Do not stop at chlamydia — ask for a full panel including gonorrhea, HIV, and syphilis when you test.

Frequently Asked Questions

How long can you have chlamydia without knowing?

Potentially years. Chlamydia can persist indefinitely without producing symptoms. Cases have been identified through routine screening in people who had no idea how long they had been infected. This is precisely why scheduled regular testing is necessary rather than symptom-triggered testing.

Can chlamydia come back after treatment?

Yes — through reinfection from an untreated partner or a new partner. Chlamydia does not produce lasting immunity. If both partners are not treated simultaneously and abstain during treatment, re-infection is very likely. A test of cure 3–4 weeks after treatment confirms clearance.

Does chlamydia always cause infertility?

No. Many people with chlamydia, even those who had it for extended periods, do not experience fertility problems. The risk increases with the number of episodes and the progression to PID. Early treatment before PID develops prevents fertility complications in the vast majority of cases.

Is chlamydia testing included in a standard STD panel?

Usually yes — most standard sexual health panels include chlamydia. However, rectal and throat chlamydia require specific swabs that are not part of a urine-only panel. If you have had anal or oral sex and want to be tested at those sites, request it specifically.

Can men get serious complications from chlamydia?

Yes. Epididymitis — inflammation of the tube behind the testicle — causes testicular pain and swelling and can affect sperm quality. Reactive arthritis (Reiter’s syndrome) is a rare but recognised complication. Untreated chlamydia in men also increases HIV susceptibility.

Get Tested Today

If you are sexually active and have not been tested for chlamydia in the past year — or ever — now is the right time. Fast, confidential testing is available at sexual health clinics, GP surgeries, and through online home testing services.

Related reading: Understanding Chlamydia · STDs and Infertility · How Often Should You Get Tested? · Can You Have an STD With No Symptoms?